Table: Oncolys Biopharma -2018 parent results
Feb 8 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2018 Dec 31, 2017 Dec 31, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 168 mln 229 mln
(-26.4 pct) (+28.5 pct)
Operating loss 1.25 loss 1.08
Recurring loss 1.23 loss 1.09
Net loss 1.23 loss 1.09
EPS loss 104.55 yen loss 106.23 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T